Greater Brisbane Area
- Supported medical device development activities aligned with ISO 13485 quality management system expectations, including objective evidence review, document control awareness, design documentation, supplier/manufacturing interfaces, and post-market risk linkages. - Developed and maintained ISO 14971 - aligned risk management documentation, including risk management planning, hazard identification, risk analysis, risk evaluation, risk control documentation, and risk management reporting. - Participated in technical file review activities and evidence gap identification to support regulatory submissions, clinical investigation planning, and conformity assessment readiness.
- The thesis focused on the mechanics of the Biphasic Plate, with emphasis on fracture fixation biomechanics, implant performance, Finite element analysis. -Developed advanced expertise in orthopaedic implant mechanics, computational modelling, fracture fixation performance, and interpretation of device-related mechanical risks.
We are developing medical technologies for accelerated healing of chronic wounds like diabetic foot ulcers, pressure sores, infected wounds etc. Our technologies overcome the challenges of clinically complex wounds by exudates removal, reducing inflammation and edema, enhancing cell proliferation and tissue perfusion and controlling microbial growth. The technology has been developed under School of International Biodesign programme, a collaborative effort between AIIMS, IIT Delhi, QUT Australia and Tottori University Japan, supported by Department of Biotechnology(DBT), Government of India, managed by Biotech Consortium India limited(BCIL).
The goal of School of International Biodesign is to train the next generation of medical technology innovators and create an ecosystem of frugal medical innovations.This is facilitated through a fellowship and events. The SIB Program is centered in New Delhi and administered as a collaboration between Stanford University, the Indian Institute of Technology Delhi, the All India Institute of Medical Sciences (AIIMS) and Queensland University of Technology. Biotechnology Consortium of India (BCIL) manages the intellectual property from the program. - Completed international medical device innovation training based on the Biodesign process, including clinical immersion, unmet clinical need identification, stakeholder engagement, concept generation, prototyping, risk considerations, and translational medical technology development. - Gained practical exposure to early-stage medical device development from clinical problem identification through concept development, prototype testing, and implementation planning.
- Supported sales and marketing activities for respiratory medical devices across the Asia-Pacific healthcare market. - Gained exposure to medical device commercial operations, customer engagement, product positioning, and healthcare stakeholder communication within a global medical technology company. - Assisted with market and product-related activities supporting respiratory care technologies and clinical customer needs.